Angel investor
Every published round Will Vicars took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Omniscient Neurotechnology | Series B | 19 Jul 2021 | $40m | Lead | Startup Daily (Wed 12 Jun 2024), Crunchbase News, Startup Daily (Mon 12 Jul 2021) |
Companies Will Vicars has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Omniscient Neurotechnology | 19 Jul 2021, Series B | 1 | 1 |
Fund closes reported for Will Vicars, as distinct from the investments it has made.
Companies Will Vicars has backed that another company then bought. An exit for the holding, not a deal Will Vicars did.
| Role | Organisation | Sources |
|---|---|---|
| No role recorded yet. Will Vicars has been mentioned, but not yet attached to an organisation. Know their role? | ||
Stories naming Will Vicars. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sydney neurotech firm Omniscient has banked a Series C from Gina Rinehart and Will Vicars, funding a push into the United States for its connectomics platform.
Sydney medtech Omniscient Neurotechnology, which applies machine learning to mapping brain networks, has reportedly raised a $40 million Series B valuing it at $400 million, with backers including Gina Rinehart, Gretel Packer, Kerr Neilson and Will Vicars.